Chemical Soup has officially unveiled the promotional trailer and key art for Quarter, an independent coming-of-age comedy-drama that explores the intersection of chronic illness and the anxieties of early adulthood. Directed jointly by Arnon Manor and Kelsey Bascom in their feature-film directorial debuts, the movie centers on Kelly, a 25-year-old woman navigating the unpredictable daily fluctuations of Type 1 Diabetes alongside the standard emotional turbulence of a quarter-life crisis. Following its initial presentation at the prestigious Tribeca Film Festival earlier in 2026, the film is scheduled to arrive in select United States theaters on November 13, 2026, distributed by Chemical Soup Production.
Narrative Premise and Personal Inspiration
The plot of Quarter revolves around Kelly—portrayed by writer, co-director, and star Kelsey Bascom—in the tense, reflective days leading up to her twenty-fifth birthday. As she struggles to maintain stable blood sugar levels, she is simultaneously forced to confront the erratic trajectory of her professional ambitions, romantic entanglements, and familial expectations. While the framing device of a "quarter-life crisis" is a familiar trope within modern cinema, the creative team has emphasized that the narrative carries a distinct level of authenticity rooted in lived experience.
Bascom drew extensively from her own personal journey as a young woman living with Type 1 Diabetes (T1D) to pen the screenplay. According to production notes, the primary motivation behind the project was twofold: to craft an intimate, character-driven narrative about resilience, and to correct the historical misrepresentation and widespread societal misunderstanding of Type 1 Diabetes in mainstream media. Unlike Type 2 diabetes—which is far more frequently depicted or referenced in popular culture—Type 1 is an autoimmune condition requiring constant insulin management and vigilance, a daily reality that Quarter aims to portray without melodramatic hyperbole or clinical detachment.
An Ensembled Cast and High-Profile Advocacy
Beyond its narrative ambitions, Quarter boasts a surprisingly robust ensemble cast featuring a blend of veteran television and film actors alongside rising talent. Alongside Kelsey Bascom in the lead role, the film stars Ali Wentworth, Breckin Meyer, Raven-Symoné, Tati Gabrielle, Brooke Shields, Eric Roberts, Nick Creegan, Matty Cardarople, and Dot-Marie Jones.
The involvement of Brooke Shields extends beyond her on-screen performance; Shields also serves as an executive producer on the project. Shields has long been an outspoken advocate for health awareness campaigns, and her attachment to Quarter underscores the production’s broader mission to destigmatize chronic illnesses. The presence of such a diverse and recognizable supporting cast has helped generate early industry buzz, elevating the profile of an indie feature that might otherwise have struggled for visibility in a crowded autumn box office landscape dominated by major studio franchise releases.
Behind the Scenes: Production and Creative Leadership
The realization of Quarter represents a milestone for its co-directors, Arnon Manor and Kelsey Bascom. Manor brings prior directorial experience to the partnership, notably having directed the acclaimed short film Cops and Robbers. Bascom, meanwhile, expands her creative portfolio following her work writing the web series Mondays.
The film’s production team is similarly collaborative, featuring production credits shared among Arnon Manor, Kelsey Bascom, Judi Bell, Ayelet Emma Regev Junger, Bri Lageyre, and Krista Minto. Financing and logistical support for independent films tackling niche subject matter often require a patchwork of independent backers, and the team successfully guided the project from its early development stages through to completion and festival submission.
Festival Circuit and Chronology of Release
The trajectory of Quarter from a localized independent production to a nationally distributed theatrical release follows a standard arthouse distribution timeline for the 2026 calendar year.
- Early 2026: Quarter completes post-production and secures a coveted selection spot at the Tribeca Film Festival, where industry screenings provide early critical feedback and gauge audience reactions to its handling of chronic illness within a comedic-drama framework.
- October 23, 2026: Chemical Soup officially releases the theatrical trailer and official promotional poster via YouTube and industry outlets, kicking off the final marketing push ahead of the premiere.
- November 13, 2026: The film is scheduled to open in limited theatrical release across select markets in the United States, allowing independent cinema enthusiasts and patient advocacy groups an early opportunity to view the picture.
Broader Impact and Industry Implications
The commercial and cultural arrival of Quarter arrives at a time when Hollywood and independent filmmakers alike are facing increased scrutiny regarding authentic representation on screen. While diversity initiatives have successfully expanded to include various racial, ethnic, and gender identities, depictions of invisible disabilities and chronic medical conditions remain comparatively rare or prone to clichéd tropes.
By utilizing comedy and drama in tandem, Quarter attempts to humanize the exhausting administrative burden of managing an autoimmune disease. For individuals living with Type 1 Diabetes, media representations often veer into extremes—either used as a convenient plot device or entirely ignored. A feature film written and headlined by someone with the condition signals a growing demand for autobiographical storytelling within the indie sector.
Furthermore, the film’s theatrical rollout in mid-November places it counter-programming against the blockbuster pre-holiday season. While multiplexes are historically occupied by high-budget action films, fantasy epics, and early-bird Oscar contenders, limited theatrical runs for indie comedies like Quarter provide a vital alternative for audiences seeking grounded, character-driven narratives. If the film resonates with viewers during its limited US theatrical window, it could pave the way for expanded digital and home-video distribution channels, broadening its reach to global audiences and T1D advocacy networks that span far beyond domestic borders.
